Nucaps Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 18

Nucaps General Information

Description

Developer of an encapsulation technology designed for the industrial development of nanocapsules and biocapsules for bioactive and probiotics. The company's technology is based on the use of food proteins such as casein, zein, or soy for the oral delivery and controlled release of drugs or actives and microorganisms, enabling clients to achieve the protection and improvement of the active ingredients introduced into the capsules.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Polígono Mocholi, Vivero CEIN
  • Nave R2, Noáin
  • 31110 Pamplona
  • Spain
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Corporate Office
  • Polígono Mocholi, Vivero CEIN
  • Nave R2, Noáin
  • 31110 Pamplona
  • Spain

Nucaps Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nucaps Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Accelerator/Incubator 01-May-2026 Completed Generating Revenue
14. Accelerator/Incubator 04-Apr-2024 Completed Generating Revenue
13. Later Stage VC 21-Nov-2023 Completed Generating Revenue
12. Accelerator/Incubator 01-Jun-2023 Completed Generating Revenue
11. Accelerator/Incubator 25-May-2023 Completed Generating Revenue
10. Seed Round 22-Feb-2023 Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
7. Grant 29-Jun-2021 $187K $709K Completed Generating Revenue
6. Seed Round 17-Mar-2020 $440K $709K Completed Generating Revenue
To view Nucaps’s complete valuation and funding history, request access »

Nucaps Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 752 $1.078260 $344.13 $344.13 1x $344.13 10.37%
To view Nucaps’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nucaps Patents

Nucaps Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025242779-A1 Particles for embedding active substances, capsules and process for obtaining them Pending 23-May-2024
US-20240342234-A1 Encapsulated phytomedicines for use against cancer Pending 13-Apr-2023

Nucaps Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nucaps Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Space F Accelerator/Incubator
RootCamp Accelerator/Incubator
Corporación Alimentaria Peñasanta (Spanish) Corporate Venture Capital Minority
Sociedad de Desarrollo de Navarra Venture Capital Minority
Socialnest Accelerator/Incubator
You’re viewing 5 of 18 investors. Get the full list »

Nucaps FAQs

  • When was Nucaps founded?

    Nucaps was founded in 2016.

  • Where is Nucaps headquartered?

    Nucaps is headquartered in Pamplona, Spain.

  • What is the size of Nucaps?

    Nucaps has 18 total employees.

  • What industry is Nucaps in?

    Nucaps’s primary industry is Biotechnology.

  • Is Nucaps a private or public company?

    Nucaps is a Private company.

  • What is Nucaps’s current revenue?

    The current revenue for Nucaps is .

  • How much funding has Nucaps raised over time?

    Nucaps has raised $1.7M.

  • Who are Nucaps’s investors?

    Space F, RootCamp, Corporación Alimentaria Peñasanta (Spanish), Sociedad de Desarrollo de Navarra, and Socialnest are 5 of 18 investors who have invested in Nucaps.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process